Podcasts about Pharma

A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week, we slither our way through our sequel season with Anacondas: The Hunt for the Blood Orchid; a movie that so aggressively undermines its own premise within the first five minutes of run time that it's actually impressive. We don't know how we ended up here, and we're certainly not happy about it.Let's yell it out now! Pharma finds flowers for furthering folk's function, forcing friends and foes to forage the forest for fauna, unfortunately, a forked tongue and fangs force fatalities and form a franchise! Snake-centered gloryholes! Hollywashing the premise! Tropical tropes on tap! Keeping a capuchin in your closet! Bushwacking for booty! Face-down open casket. Unquaffable waterfall hair? Gyrating sex balls! The Jungle Jack Smash! Unconsenting stock options, and much, much more on this week's episode of The Worst Movie Ever Made!www.theworstmovieevermade.com

As markets slumped, tariffs increased, and disappointing unemployment numbers landed, the Rise UP! Team asks, should you be worried? Rise Growth Managing Partner Joe Duran is joined by OnePoint BFG Wealth Partners, Managing Partner Scott Schwartz, and Director of Investment Research Alexis Miller to break down what happened in markets this week and what smart investors are doing right now to stay ahead. They discuss why diversification is finally beating Big Tech, how rebalancing helped them nearly bottom-tick the April dip, and what they're doing now as markets are still too high and risks keep rising. Plus, why healthcare stocks remain compelling, and how tariffs may quietly squeeze earnings or impact consumer wallets. Get Scott and Alexis' great insights one-on-one with a free review of your portfolio. Go to https://www.wealthion.com/free and select OnePoint BFG Wealth Partners on the form. Hard Assets Alliance - The Best Way to Invest in Gold and Silver: https://www.hardassetsalliance.com/?aff=WTH Chapters: 2:54 - Markets Are Now Taking a Hit 10:07 - Pharma and Healthcare Sectors Are Under Fire 14:47 - Coinbase Is Tokenizing “Everything” 18:35 - What Will Tariffs Ultimately Affect - Company Earnings or Consumer Wallets? 22:20 - When Will We Know We've Overcome Stagflation? 23:37 - How Much Do I Need for Liquidity Needs + Can a Wealth Manager Help? 26:25 - What Data Investors Should Pay Attention to 27:31 - Atlanta Fed President to Speak Next Week & Fed Fund Rates 28:42 - Pharma Earnings to Come Out - What to Watch for Connect with us online: Website: https://www.wealthion.com X: https://www.x.com/wealthion Instagram: https://www.instagram.com/wealthionofficial/ LinkedIn: https://www.linkedin.com/company/wealthion/ #Wealthion #Wealth #Finance #Investing #StockMarket #Rebalancing #Tariffs #Diversification #HealthcareStocks #SmartInvesting #MarketRisk #FedWatch #AIStocks #Stagflation #Tokenization ________________________________________________________________________ IMPORTANT NOTE: The information, opinions, and insights expressed by our guests do not necessarily reflect the views of Wealthion. They are intended to provide a diverse perspective on the economy, investing, and other relevant topics to enrich your understanding of these complex fields. While we value and appreciate the insights shared by our esteemed guests, they are to be viewed as personal opinions and not as investment advice or recommendations from Wealthion. These opinions should not replace your own due diligence or the advice of a professional financial advisor. We strongly encourage all of our audience members to seek out the guidance of a financial advisor who can provide advice based on your individual circumstances and financial goals. Wealthion has a distinguished network of advisors who are available to guide you on your financial journey. However, should you choose to seek guidance elsewhere, we respect and support your decision to do so. The world of finance and investment is intricate and diverse. It's our mission at Wealthion to provide you with a variety of insights and perspectives to help you navigate it more effectively. We thank you for your understanding and your trust. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Theory & Insights, we bring together two thought leaders at the intersection of healthcare innovation and pharmaceutical manufacturing — John Nosta, renowned AI and technology theorist and founder of NostaLab, and Stephen Beckman, CEO of YARAL Pharma, a rising force in U.S. generics. Together, they dive into the evolving impact of Artificial Intelligence (AI) and Large Language Models (LLMs) on pharmaceutical manufacturing. The discussion covers the promise and peril of AI in reshaping everything from R&D to regulatory pathways, as well as the ethics, economics, and operational shifts that could redefine the industry in the next decade. This is a must-listen for pharma execs, digital health strategists, and technology innovators looking to understand what's next.

Der Amerikanische Katzenwels hat die Abpump-Aktion im Steinbruchweiher überlebt, dänische Kette „Søstrene Grene“ kommt nach Gießen und Marburgs Zukunft als Pharma- und Forschungsstandort in Gefahr. Das und mehr heute im Podcast. Alle Hintergründe zu den Nachrichten des Tages finden Sie hier: https://www.mittelhessen.de/lokales/lahn-dill-kreis/herborn/gefaehrlicher-fisch-in-see-bei-herborn-neue-details-bekannt-4836861 https://www.mittelhessen.de/lokales/kreis-giessen/giessen/sostrene-grene-eroeffnet-filiale-in-giessen-4638944 https://www.mittelhessen.de/lokales/kreis-marburg-biedenkopf/biedenkopf/kreis-haelt-an-plaenen-fuer-drk-krankenhaus-biedenkopf-fest-4841431 https://www.mittelhessen.de/lokales/kreis-marburg-biedenkopf/marburg/demo-gegen-stellenabbau-am-pharmastandort-marburg-4842020 https://www.mittelhessen.de/politik/politik-hessen/wegen-eritrea-festival-hofheim-verhaengt-waffenverbotszone-4841285 https://www.mittelhessen.de/panorama/aus-aller-welt/management-laura-dahlmeier-toedlich-verunglueckt-4839960 Ein Angebot der VRM.

In this episode, YARAL Pharma CEO, Stephen Beckman joins clinical sports pharmacist Jessica Beal, PharmD. to discuss an important topic for athletes and active individuals – the role topical NSAID patches can play in acute pain management. Listeners can visit www.YARALPharma.com to learn more about the company and its products or connect on LinkedIn.    Diclofenac Epolamine Topical System 1.3%    Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) used for treating acute pain from minor strains, sprains, and bruises in adults and children aged 6 and older.     Serious side effects may include increased risk of cardiovascular and gastrointestinal (GI) events. NSAIDs can raise the risk of heart attack, stroke, gastrointestinal bleeding, ulceration, and perforation of the stomach and intestines, which can be fatal. The risk for serious cardiovascular events may occur early in treatment and may increase with duration of use. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at higher risk for serious GI events.    Do not use in patients who are allergic to diclofenac or any of its ingredients, or have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Do not use in the setting of coronary artery bypass graft surgery. Avoid use on broken skin. Discontinue immediately if signs of hypersensitivity occur.      Patients should be informed about the warning signs and symptoms of liver problems. Discontinue use if abnormal liver tests persist or worsen or if signs of liver disease develop. Avoid using Diclofenac Epolamine Topical System 1.3% in patients with severe heart failure unless the benefits are expected to outweigh the risks.    The most common side effects include itching, nausea, and headache. Patients should stop use and consult their doctor at the first sign of skin rash or other signs of sensitivity.    Patients should ask their doctor if Diclofenac Epolamine Topical System 1.3% is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit www.yaralpharma.com   Dr. Beal is not affiliated with YARAL Pharma. All views and opinions regarding pain management are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. 

Former NEC Director and former Goldman Sachs President Gary Cohn reacts to this morning's GDP print and the President's continued call for the Fed to lower rates. Plus an exclusive with the CEO of Oreo maker Mondelez, raising prices to offset an “unprecedented” rise in cocoa prices. Then the CEO of Teva Pharma breaks down the impact of tariffs for the Israeli based company, after narrowing its full-year outlook. And Finally what results from Meta and Amazon could signal about the AI opportunity in the ad market.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Novo Nordisk has announced Maziar Mike Doustdar as its new CEO, along with a 5% reduction in its 2025 sales guidance. This decision comes as a response to the slowed growth of its semaglutide franchise in the U.S. Senate Democrats are currently looking into HHS Secretary RFK Jr.'s controversial move to dismiss all 17 members of the CDC's vaccine advisory committee. Astrazeneca CEO Pascal Soriot emphasized the importance of global collaboration in pharmaceutical research and development. Merck has allocated $3 billion to support upcoming product launches. In a surprising turn of events, the FDA has reversed its decision on Sarepta, now permitting DMD gene therapy for ambulatory patients.

“I'm a Barbie girl in the medical marketing world?”One year after rebranding from the Juvenile Diabetes Research Foundation to Breakthrough T1D, the healthcare advocacy organization made headlines earlier this month for its work on the latest Barbie doll.Breakthrough T1D collaborated with Mattel to create the first Barbie doll to feature a continuous glucose monitor (CGM) and an insulin pump.The doll has been well-received, particularly among patient advocates who say the partnership brings renewed attention to type 1 diabetes – a condition that affects an estimated 2 million Americans.MM+M summer intern Lola Offenback spoke with a pair of leaders from Breakthrough T1D about working with Mattel to bring a Barbie with type 1 diabetes to life, how the project elevates the experience of those living with the condition and the key marketing lessons for other health brands.-TRENDSFor the Trends segment, our reporter Heerea Rikhraj walks us through the Depo-Provera controversy affecting Pfizer and what medical marketers need to know about it. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.

Angel Studios https://Angel.com/ToddJoin the Angel Guild today and stream Testament, a powerful new series featuring the retelling of the book of Acts. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bioptimizers https://Bioptimizers.com/toddEnter promo code TODD to get 10% off your order of Berberine Breakthrough today.Bizable https://GoBizable.comUntie your business exposure from your personal exposure with BiZABLE.  Schedule your FREE consultation at GoBizAble.com today.  Bonefrog https://BonefrogCoffee.com/toddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/ToddLISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeShooting in Manhattan and a Columbine Father's Extraordinary Testimony // The Return of the Insane Asylum: Necessary Step or PayDay for Pharma? // Heretical “Pastor“ Thinks Colors Mean You Are Same-Sex AttractedEpisode Links:Shooting in NYCActive shooter on Park Avenue in Midtown Manhattan. Is " most likely a white guy "! CNN is out of their minds! Does he look white to y'all!?Darrell Scott Speech on CSPANTrump issues EO to bring back ‘insane asylums'…UMC pastor explains that Joseph's brother's hated him because he was super gay, pretty, and wore women's clothing. "Joseph had the nerve to prance about in that ridiculous fruity dress … so when the brothers had a chance, they decided to bash the queerness right out of him"

01:02:44 – Technocrat Sun-Dimming Agenda ExposedScientists and agencies—backed by billionaires—quietly prepared to spray aerosols into the atmosphere to block sunlight. With no public consent, the plan evokes the reckless spirit of atomic bomb testing: high-risk, zero accountability. 01:06:44 – Geoengineering for Global ControlWhat was once dismissed as conspiracy is now openly admitted. Weather manipulation is being normalized by researchers and bureaucrats, laying the foundation for global governance under the guise of climate intervention. 01:18:22 – Christians and Fake News: A WarningBelievers are urged to stop spreading clickbait and false headlines. The warning is clear: reckless sharing of fake stories harms credibility and undermines the real fight for truth. 01:49:37 – Gosar's Bill to Nuke Vax ImmunityRep. Paul Gosar pushes legislation to dismantle the 1986 Vaccine Act and PREP Act protections. It's a direct strike on Big Pharma's legal shield—and long overdue. 02:07:00 – COVID Lockdowns Crushed a GenerationNew data confirms what many feared: lockdowns stunted cognitive and social development in children. From masks to screen addiction, a generation was psychologically engineered into submission. 02:26:54 – Every Warning Came TrueWarnings about mRNA risks, genetic alteration, and immune dysfunction have all been vindicated. The technocratic obsession with experimental medicine—especially under Trump—is blamed for the fallout. 02:33:23 – Pharma's Redemption Arc is a LieThe opioid crisis briefly shattered Big Pharma's credibility—only for COVID to bring a mass forgiveness campaign. The same entities that fueled addiction were repackaged as heroes. 02:37:18 – Moderna's First “Success” Was Skipping Animal TestingModerna's vaccine only made it to market by bypassing normal safety trials. Previous versions had failed due to serious animal side effects—but COVID exemptions paved the way. 02:41:04 – Exploiting a Child's Death for Fear PropagandaOfficials obscure the vaccine status of a child who died from measles complications, crafting a narrative designed to manipulate parents and push compliance. 02:47:10 – American Golf Courses: Legalized Poison ZonesU.S. golf courses are doused in toxic pesticides far beyond European norms. The result? Quiet chemical exposure and chronic health fallout in surrounding communities. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

01:02:44 – Technocrat Sun-Dimming Agenda ExposedScientists and agencies—backed by billionaires—quietly prepared to spray aerosols into the atmosphere to block sunlight. With no public consent, the plan evokes the reckless spirit of atomic bomb testing: high-risk, zero accountability. 01:06:44 – Geoengineering for Global ControlWhat was once dismissed as conspiracy is now openly admitted. Weather manipulation is being normalized by researchers and bureaucrats, laying the foundation for global governance under the guise of climate intervention. 01:18:22 – Christians and Fake News: A WarningBelievers are urged to stop spreading clickbait and false headlines. The warning is clear: reckless sharing of fake stories harms credibility and undermines the real fight for truth. 01:49:37 – Gosar's Bill to Nuke Vax ImmunityRep. Paul Gosar pushes legislation to dismantle the 1986 Vaccine Act and PREP Act protections. It's a direct strike on Big Pharma's legal shield—and long overdue. 02:07:00 – COVID Lockdowns Crushed a GenerationNew data confirms what many feared: lockdowns stunted cognitive and social development in children. From masks to screen addiction, a generation was psychologically engineered into submission. 02:26:54 – Every Warning Came TrueWarnings about mRNA risks, genetic alteration, and immune dysfunction have all been vindicated. The technocratic obsession with experimental medicine—especially under Trump—is blamed for the fallout. 02:33:23 – Pharma's Redemption Arc is a LieThe opioid crisis briefly shattered Big Pharma's credibility—only for COVID to bring a mass forgiveness campaign. The same entities that fueled addiction were repackaged as heroes. 02:37:18 – Moderna's First “Success” Was Skipping Animal TestingModerna's vaccine only made it to market by bypassing normal safety trials. Previous versions had failed due to serious animal side effects—but COVID exemptions paved the way. 02:41:04 – Exploiting a Child's Death for Fear PropagandaOfficials obscure the vaccine status of a child who died from measles complications, crafting a narrative designed to manipulate parents and push compliance. 02:47:10 – American Golf Courses: Legalized Poison ZonesU.S. golf courses are doused in toxic pesticides far beyond European norms. The result? Quiet chemical exposure and chronic health fallout in surrounding communities. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode the Pharma Boys review the game against San Diego FC and preview Nashville's first ever meeting with a Premier League side. Stay for the end, you dont want to miss Valair's new game!  As always, thanks for listening! 

How can industry close the screening gap in breast cancer? Find out in this episode, where Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in imaging today. Together, Jade and Joana discuss her initial interest in a career in radiology, the pivotal role of professional societies in accelerating innovation, how AI is shaping the future of the field and much more. A little more on EMJ GOLD's guest… Dr Joana Reis was appointed Medical Affairs Breast Lead for radiology at Bayer in January of 2025. Before this, she was the Medical Affairs Lead for digital radiology at the company, where she developed strategies focusing on AI applications in imaging. Before joining Bayer, Joana worked as a Senior Consultant Breast Radiologist at Akershus University Hospital in Oslo, Norway.

Ursula and Donald came to a deal but were they thinking about our jobs in Cork or was their focus in their own backyard? Paul talks to Conor Healy of Cork Chamber Hosted on Acast. See acast.com/privacy for more information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. GSK has entered a partnership with Hengrui worth up to $12 billion, focusing on the COPD candidate HRS-9821. The FDA's new voucher policy has caused confusion among experts, as it lacks clear definition and was announced without public input. The American Medical Association urges RFK Jr. to maintain the preventive task force, and Sarepta denies a patient death is linked to Elevidys as the FDA launches a probe. Biopharma companies are leaning towards holistic treatments for Alzheimer's, while Atai-partnered schizophrenia drug fails in a mid-stage trial. Boehringer partners with Irish startup Re-Vana in a $1 billion+ eye deal.As the Alzheimer's space becomes more competitive, biopharma companies are focusing on holistic treatments beyond disease-modifying drugs like Leqembi and Kisunla. Companies such as Bristol Myers Squibb, Acadia, Otsuka, and Lundbeck are renewing their search for symptomatic treatments. Five upcoming data drops could potentially lead to more effective therapies for Alzheimer's. Sarepta Therapeutics is facing challenges due to safety concerns surrounding its gene therapies, leading to a drop in stock value. The FDA's new voucher program aims to offer accelerated pathways for drugs meeting certain criteria, but experts criticize the lack of transparency and public input in the policy's announcement. Sarepta's future is uncertain as the FDA considers a new study for Elevidys, and the EU issues a negative opinion on the drug. Other news includes delays in the FDA decision on GSK's Blenrep, AstraZeneca's PIII win with nanobody treatment for myasthenia gravis, and the removal of thimerosal from influenza vaccines. George Tidmarsh has been appointed as the new chief of FDA's CDER.

A 15% EU-US tariff deal is preferable to a “ruinous” trade war, according to the Taoiseach, as talks continue on the finer details, including potential exemptions for key sectors. Will pharma be among them? Joining Shane Coleman was Cathal Friel, Chairman and co-founder Poolbeg Pharma.

What do cross-country vespa races, edgy stand-up comedy, business leadership in a thriving Pharma industry, a children's book series about a cat, purchasing property to reinvent small town America, and an international travel vlog series have to do with us? Well, it's how our guest – Zaidoon A. Al-Zubaidy (aka Z) – spent his last 10 years. But it wasn't always a shits and giggles adventure for this charismatic, dapper SOB! Listen as Z goes back to the beginning, when he was living in poverty, just trying to make ends meet. When his back was against the wall, he took the entrepreneurial leap… because he had nowhere else to go. Join Don and Steve for this inspiring episode – It will get you laughing and thinking about life's bigger picture. Oh, and Pufty also makes a visit too lol.Clean Eatz - www.cleaneatz.comBonseye Marketing - www.bonseyeonline.comFounderz Lounge - www.thefounderzlounge.comhttps://instagram.com/donvarady https://instagram.com/stevebon8https://instagram.com/thefounderzlounge https://instagram.com/founderzlounge Clean Eatz - http://www.cleaneatz.comBonseye Marketing - http://www.bonseyeonline.comFounderz Lounge - http://www.thefounderzlounge.com

From Wall Street to Main Street, the latest on the markets and what it means for your money. Updated regularly on weekdays, featuring CNBC expert analysis and sound from top business newsmakers. Anchored by CNBC's Jessica Ettinger.

Jon Ihle, Deputy Business Editor with the Sunday Times // Tom Keogh, Managing Director of Keogh's Crisps // Peter Brown, Managing Director, Baggot Investment Partners.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The European Medicines Agency's CHMP did not recommend approving Elevidys for ambulatory patients with Duchenne muscular dystrophy, dealing a blow to Sarepta. FDA is rumored to request new data for Elevidys, leading to uncertainty as FDA considers a new study for the drug. In other news, Eli Lilly commits $856 million to Gate Bioscience for a new class of medicines, while Rocket trims headcount and pipeline focus. Roche also drops an early obesity asset as layoffs continue in the biopharma industry, with companies like Adicet optimizing their pipelines. Novartis makes a billion-dollar drug discovery deal with Matchpoint, and the FDA opens a pilot run of the commissioner voucher program.Stay tuned for more updates on the latest developments in the pharmaceutical and biotech world.

A Clare MEP believes uncertainty for the pharmaceutical sector in the Midwest will continue as a result of the framework trade agreement signed by the EU and US. The deal signed yesterday imposes a 15% import tariff on the majority of EU goods including pharmaceuticals which it was hoped would be exempted. The outcome of talks has been welcomed across the Government with the Taoiseach claiming it will bring "clarity and predictability" to the trading relationship. Scariff Independent MEP Michael McNamara has been telling Clare FM's Seán Lyons the US President appears to have got what we came for and may come back for more.

Becker, Birgid www.deutschlandfunk.de, Wirtschaft am Mittag

AI has revolutionized drug discovery by enabling scientists to process vast amounts of historical data, thus accelerating the identification of disease targets and molecule development. AI helps avoid past mistakes and improves the quality of research, making it an indispensable tool in the lab. MSD's approach to AI involves a blend of internal talent and strategic partnerships. By combining computational and web science expertise, MSD ensures that both technological and scientific endpoints are effectively addressed, says Matt Studney, SVP of Research Labs at MSD. Topics addressed: Internal vs. External AI Development at MSD Global Data Management Challenges Generative AI's Impact on Drug Discovery Confidential AI Systems and Documentation Challenges in AI Integration Workforce Upskilling and Cultural Change Future Breakthroughs and Concerns Synthetic Data and Drug Repurposing www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Youtube: https://youtu.be/pgCz-tgHaL0

Find Shana here on Instagramher Food Over Pharma page hereand her business Farmonius Plantersons hereSome of Shana's recommendations:Weston A. PriceFind Raw Milk  in your area hereSally's Fallon's Nourishing Traditions Cookbook hereRead the study Shana references about the African tribe's gut health americanfarmsteadhers.com americanfarmsteadconvention.com

Elevidys shipments paused following third death; FDA committee votes against brexpiprazole combo for PTSD; Rapiblyk now available for SVT; sleep apnea pill looks promising; JUUL e-cigarettes gain marketing authorization.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has dropped an early-stage obesity asset, CT-173, citing lack of competitiveness. Novartis has entered into a drug discovery deal with Matchpoint Therapeutics, acquiring global rights on all molecules for several inflammatory diseases. AstraZeneca claims a Phase III win with its nanobody treatment for myasthenia gravis. Second-quarter earnings season is approaching, and biotechs to watch include Sarepta and others facing challenges in the biopharma industry. Genentech downsizes as priorities shift, and GSK's comeback for Blenrep is on pause as the FDA delays its decision. The FDA's lack of transparency has tarnished Sarepta's reputation after patient deaths triggered an FDA battle. Opportunities in the industry include roles like Quality Specialist at CSL and Clinical Research Physician at Eli Lilly and Company.

Trailer del prossimo episodio dal titolo:I mestieri dell'intelligenza artificiale: chi sale e chi scende. Intervento di Gabriele Ghirlanda, Executive Director Global Value, Access & Public Affairs di Angelini Pharma al Festival dell'Economia di Trento Edizione 2025

L'episodio di oggi rappresenta la versione podcast di uno degli interventi del top management di Angelini Industries al Festival dell'Economia di Trento edizione 2025.  In questo episodio lo speech di Gabriele Ghirlanda, Executive Director Global Value, Access & Public Affairs di Angelini Pharma, nel panel dal titolo “I mestieri dell'intelligenza artificiale: chi sale e chi scende”, un confronto sulle trasformazioni del mondo del lavoro nell'era dell'IA. Quali professioni stanno emergendo, quali rischiano di scomparire e come prepararsi al cambiamento? Esploreremo le competenze richieste, settori in crescita e sfide etiche legate all'avvento dell'artificial intelligence e al supporto alle professioni. Alcuni key numbers dell'edizione 2025 del Festival: * Oltre 750 ospiti, tra cui    * 115 personalità dal mondo accademico nazionale ed internazionale    * 45 economisti    * 6 Premi Nobel    * 66 rappresentanti delle istituzioni    * 17 Ministri del Governo    * Oltre 60 esponenti della business community economica e finanziaria* 325 appuntamenti tra panel, dirette radio, laboratori ed incontri con autori* Oltre 200 eventi disponibili per gli utenti registrati in versione on demand sulla piattaforma ufficiale del Festival* 60 partner dell'iniziativa nell'edizione 2025* 22 location scelte come luoghi del Festival, nei più affascinanti palazzi e piazze della città di Trento 

Ein Antibiotikum, das eigentlich ganz andere Zwecke erfüllen sollte, sorgt bei Mäusen plötzlich für ein längeres Leben. Doch wie genau funktioniert das? Und: Was passiert, wenn Menschen sich diesen Stoff einfach selbst verabreichen? In dieser Folge geht es um „mTOR“, Krebs, und die vielleicht unterschätzteste Anti-Aging-Methode: Hunger. 00:38 Maus und Bakterium 03:26 Länger leben ≠ besser leben 05:13 Die Nachteile 09:59 Fasten statt Pharma?

In this episode of SCW for Pharma, Evren Ozkaya welcomes Adrian Van den Hoven, Director General of Medicines for Europe, the leading voice for generic and biosimilar manufacturers across the continent.The conversation begins by underscoring the essential role generics and biosimilars play in Europe's healthcare system — making up around 90% of prescriptions but only 20% of total costs. Adrian explains how these medicines significantly expand access while easing the burden on patients and insurers. However, despite their public health value, low profit margins have led to a fragile and highly consolidated market — one responsible for two-thirds of medicine shortages across Europe, a trend also seen in the U.S.Evren and Adrian explore how geopolitical tensions, supply chain disruptions, and stringent environmental regulations are putting additional pressure on the sector. While EU authorities are assessing ways to strengthen local supply, current pricing models offer little incentive for generic manufacturers to invest in capacity or modernization. Today, 70% of manufacturing investment goes toward maintaining compliance, leaving only 30% for productivity, agility, or innovation — eroding Europe's competitiveness against countries like China and India.Digital transformation surfaces as a crucial lever — not just to improve efficiency but also to combat labor shortages and build greater resilience. Yet Adrian notes that digital maturity in EU pharma remains low, with many factories still running on paper and Excel. Still, the opportunity is enormous. As Evren highlights, PwC estimates that AI could potentially double EBITDA for pharma, especially through manufacturing and supply chain use cases. But he also cautions that most companies aren't ready to harness AI due to weak data infrastructure. Without high-quality, real-time operational data, AI delivers poor results — “garbage in, garbage out.”The episode concludes with a look ahead. Adrian stresses that Europe has the skilled workforce to lead in digital transformation, but regulatory support and targeted funding are essential. Strategic partnerships — like the one between SCW.AI and Medicines for Europe — can help bridge the gap. Evren and Adrian close by previewing their upcoming meeting in Brussels with the European Commission, generic pharma manufacturers, and technology providers — a collaborative push to showcase ROI, align stakeholders, and accelerate digital transformation across the industry.

Tonight we welcome Barbie Rivera https://barbierivera.com/ , whose personal experience with the school system's attempts to medicate her son, put her on a homeschooling path that has resulted in the publishing of a book. Tonight we are going to talk about the influence of Pharma in the schools, and the "experts" who have run American Education completely into the ground. In the second half, Tulsi Gabbard continues to release new waves of evidence that exposes the Obama Administration's role in the 2016 Russia-op. Unleash Your Brain w/ Keto Brainz Nootropic Promo code FRANKLY: https://tinyurl.com/2cess6y7 Sponsor The Show and Get VIP Perks: https://www.quitefrankly.tv/sponsor One-Time Tip: http://www.paypal.me/QuiteFranklyLive Read July Newsletter: https://tinyurl.com/y4yvuxff Elevation Blend Coffee & Official QF Mugs: https://www.coffeerevolution.shop/category/quite-frankly Official QF Apparel: https://tinyurl.com/f3kbkr4s Send Holiday cards, Letters, and other small gifts, to the Quite Frankly P.O. Box! Quite Frankly 222 Purchase Street, #105 Rye, NY, 10580 Send Crypto: BTC: 1EafWUDPHY6y6HQNBjZ4kLWzQJFnE5k9PK Leave a Voice Mail: https://www.speakpipe.com/QuiteFrankly Quite Frankly Socials: Twitter/X: @QuiteFranklyTV Instagram: @QuiteFranklyOfficial Discord Chat: https://discord.gg/KCdh92Fn GUILDED Chat: https://tinyurl.com/kzrk6nxa Official Forum: https://tinyurl.com/k89p88s8 Telegram: https://t.me/quitefranklytv Truth: https://tinyurl.com/5n8x9s6f GETTR: https://tinyurl.com/2fprkyn4 MINDS: https://tinyurl.com/4p84d3cx Gab: https://tinyurl.com/mr42m2au Streaming Live On: QuiteFrankly.tv (Powered by Foxhole) Youtube: https://tinyurl.com/yc2cn395 BitChute: https://tinyurl.com/46dfca5c Rumble: https://tinyurl.com/yeytwwyz Kick: https://kick.com/quitefranklytv Audio On Demand: Spotify: https://spoti.fi/301gcES iTunes: http://apple.co/2dMURMq Amazon: https://amzn.to/3afgEXZ SoundCloud: https://tinyurl.com/yc44m474

Janet returns to Paranoi Radio to expose the hidden world of red light therapy—this time diving deeper into ancient healing tech, secret medical procedures, and the frequencies they don't want you absorbing. From underground clinics to forgotten light rituals, this episode uncovers the power of light to heal, control, and awaken.CONTACT DEPLORABLE JANET VISIT DEPLORABLE NATION// Paranoi Radio is on YouTube

This Day in Legal History: Apollo 11On July 24, 1969, the Apollo 11 mission concluded when astronauts Neil Armstrong, Buzz Aldrin, and Michael Collins safely splashed down in the Pacific Ocean, returning from the first successful lunar landing. While the event was widely celebrated as a scientific and political triumph, it also raised an unexpectedly terrestrial legal issue: customs law. Upon returning to Earth, the astronauts were required to fill out a standard U.S. Customs declaration form. The departure point was listed as “Moon,” and the flight number: “Apollo 11.” Among the items declared were “moon rock and moon dust samples,” brought back from the lunar surface.Despite their unprecedented journey, the crew still had to comply with Department of Agriculture and Customs rules designed to monitor and control potentially hazardous biological materials. In the “Declaration of Health” section of the form, they noted that the presence of any condition that could spread disease was “To be determined.” This moment captured how U.S. law, even in its most routine forms, extended to the edge of human experience.The astronauts' re-entry into the U.S. technically triggered the same legal processes that greet travelers arriving from abroad. This event also underscored the broader legal challenge of adapting existing statutes to cover entirely new domains like space travel. Though humorous in hindsight, the customs declaration reflected a serious concern: whether extraterrestrial material might carry unknown biological risks.The completed form, now a historical artifact, reminds us that legal frameworks often evolve reactively. In 1969, space law was largely uncharted territory. Today, those early steps form part of the foundation for international agreements like the Outer Space Treaty and modern debates over resource rights beyond Earth.The U.S. Supreme Court granted President Donald Trump the authority to remove three Democratic members of the Consumer Product Safety Commission (CPSC), reversing a lower court ruling that had temporarily blocked the dismissals. The CPSC was established by Congress in 1972 as an independent agency to protect the public from hazardous products, and its members were traditionally shielded from at-will removal by the president. The justices, in a brief unsigned order, suggested that Trump was likely to prevail in arguing that the Constitution gives him broad authority to remove executive officials, even from agencies Congress meant to be independent.This move followed a June ruling by District Judge Matthew Maddox, who sided with the ousted commissioners, citing a 1935 Supreme Court precedent (Humphrey's Executor v. United States) that upheld removal protections for independent agency officials. The Supreme Court's majority, with all three liberal justices dissenting, appeared to undermine that precedent. Justice Elena Kagan's dissent warned that using the Court's emergency docket to erode agency independence risked shifting constitutional power toward the presidency.The fired commissioners, whose terms extended through 2025 to 2028, had sued Trump, arguing their removal lacked legal justification. Their attorney, Nicolas Sansone, criticized the Court's decision as harmful to public safety oversight. The Justice Department, however, contended that limiting the president's removal power was unconstitutional.This decision echoes a similar ruling in May allowing Trump to remove members of other federal boards, reinforcing a pattern of the Court endorsing expanded executive control over federal agencies.US Supreme Court lets Trump remove consumer product safety commissioners | ReutersSupreme Court Lets Trump Oust Top Consumer-Safety Officials - BloombergU.S. District Judge Julien Xavier Neals withdrew a June 30 opinion in a securities fraud case against CorMedix Inc. after attorneys pointed out significant factual and legal errors. Lawyers flagged that the opinion included invented quotes, misattributed statements, and references to non-existent or misidentified cases. Among the problems was a supposed quote from Dang v. Amarin Corp. about “classic evidence of scienter,” which does not appear in the actual case, as well as misquoted content from a case involving Intelligroup and a fabricated citation to a Verizon case in the Southern District of New York.The withdrawn opinion had denied CorMedix's motion to dismiss a shareholder lawsuit alleging the company misled investors about its FDA approval efforts for the drug DefenCath. CorMedix's counsel, Andrew Lichtman of Willkie Farr & Gallagher, raised concerns but clarified he wasn't seeking reconsideration, only correction of the record. The same opinion had been cited as persuasive authority in a separate but similar shareholder lawsuit against Outlook Therapeutics Inc., before being discredited due to its inaccuracies.The incident drew attention not just for the mistakes themselves, but because judicial errors of this nature are rare—especially when resembling the kind of AI-generated errors that have recently led to lawyer sanctions. There is no indication AI was involved in drafting Judge Neals' opinion, but the situation reflects heightened scrutiny of legal drafting in an era where reliance on technology is increasing.Judge Withdraws Pharma Opinion After Lawyer Flags Made-Up QuotesColumbia University has agreed to pay over $200 million to the U.S. government in a settlement with the Trump administration, resolving federal investigations and securing the reinstatement of most of its previously suspended federal funding. The dispute stemmed from Columbia's handling of pro-Palestinian campus protests and alleged antisemitism, which led the administration in March to freeze $400 million in grants. In addition to the main settlement, Columbia will pay $21 million to resolve claims brought by the Equal Employment Opportunity Commission.The agreement includes several conditions: Columbia must discipline students involved in severe campus disruptions, reform its Faculty Senate, review its international admissions process, and overhaul its Middle Eastern studies programs to promote “viewpoint diversity.” The university is also required to eliminate race-based considerations in hiring and admissions and to dismantle its diversity, equity, and inclusion (DEI) programs.Columbia has agreed to appoint two new administrators: one to oversee compliance with the settlement and another to address antisemitism. The university has also severed ties with the pro-Palestinian group Columbia University Apartheid Divest and adopted a new definition of antisemitism that equates it with opposition to Zionism—moves that have sparked backlash among students and faculty.Rights advocates have voiced alarm over academic freedom and due process, especially amid reports of deportation attempts against foreign pro-Palestinian students. Critics say the government is equating legitimate political protest with antisemitism, while ignoring rising Islamophobia and anti-Arab bias.Columbia University to pay over $200 million to resolve Trump probes | ReutersFrench President Emmanuel Macron and his wife, Brigitte Macron, have filed a defamation lawsuit in Delaware against U.S. right-wing podcaster Candace Owens, alleging she spread false and harmful claims about Brigitte's gender identity. The suit centers on Owens' podcast series Becoming Brigitte, which claims Brigitte was born male under the name Jean-Michel Trogneux—actually the name of her older brother—and accuses the couple of incest and identity fraud. The Macrons argue these assertions amount to a global smear campaign intended to boost Owens' profile and cause personal harm.Owens responded by labeling the lawsuit a politically motivated PR move and maintained it is an attack on her First Amendment rights. Her spokesperson framed the suit as a foreign government's attempt to silence an American journalist. The Macrons, however, stated that they had made multiple requests for a retraction, all of which Owens ignored.Defamation lawsuits by sitting world leaders are rare, and as public figures, the Macrons must meet the high legal bar of proving “actual malice”—that Owens knowingly spread falsehoods or acted with reckless disregard for the truth. The complaint also notes the rumors originated in 2021 and were amplified by other high-profile commentators like Tucker Carlson and Joe Rogan. A similar French court case involving Brigitte ended in a temporary victory, but was later overturned on appeal and is now pending before France's highest court.French president Macron sues right-wing podcaster over claim France's first lady was born male | Reuters This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA has initiated a voucher program to address lower drug prices and boost domestic investment, with up to five companies being selected based on national priorities. Roche has halted shipments of Sarepta's Elevidys gene therapy after reports of patient deaths. Sarepta is under FDA scrutiny following a third patient death, while the agency welcomes a new top drug regulator and rejects multiple new drugs from entering the market. Insights from women in biopharma highlight the importance of resilience. Zhen Li, an engineer, is playing a crucial role in shaping the field of siRNA. Research suggests that GLP-1s may offer protection against neurodegenerative diseases. Dispatch Bio enters the scene with a substantial $216 million investment for universal CAR T therapy. Sarepta complies with an FDA request to suspend US shipments of Elevidys, raising concerns about transparency and impacting the company's reputation. Replimune experiences a significant drop in stock value following an FDA rejection, while AstraZeneca makes a bold $50 billion investment in US manufacturing to prepare for potential tariffs. Thank you for tuning in to Pharma and Biotech daily for the latest updates in the industry.

When it comes to HHS, hundreds of thousands of people have either been fired or left on their own volition as the Trump administration has sought to streamline the federal bureaucracy and reimagine the very idea of career civil service.Some companies have tried to take advantage of the brain drain, such as one 2025 MM+M Agency 100 honoree.In April, Avalere Health announced a number of personnel moves – including the appointment of Mark Newsom to its advisory team. Most recently, Newsom served as the deputy group director for the Centers for Medicare and Medicaid Services (CMS) in the Biden administration. Newsom also previously served in leadership posts at CMS under Presidents George W. Bush and Barack Obama.In a conversation with our pharma editor Lecia Bushak, Newsom talks about making the jump to the world of medical marketing and how he plans to utilize his experience leveraging data to improve operational performance, inform business strategy and evaluate policy decisions.For the Trends segment, our summer intern Lola Offenback fills us in on how medical marketing agencies are treating their summer interns ahead of National Intern Day. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sarepta Therapeutics has halted the distribution of Elevidys in the US after the FDA request, following two deaths. The company's transparency has been called into question, affecting its stock value. Replimmune also faced setbacks after the FDA rejected its melanoma treatment, causing a significant drop in shares. On a more positive note, AstraZeneca has pledged $50 billion for US manufacturing, focusing on drugs like Baxdrostat and oral glp-1 therapies. Sanofi has made a $1.6 billion vaccine acquisition, while Biogen commits $2 billion to expand US drug production. The pharmaceutical industry is seeing various developments and challenges, with companies adapting to regulatory demands and market pressures.

260: My wellness bestie Illie is here and we are not holding back. Her brand, Live Healthillie, promotes clean living through everything from food, to skincare to supplements. Like me, she's been super vocal about exposing the toxins that lurk in our food supply and pushing for change on a national scale. We yapped so hard that we needed to make the conversation into two parts. This was like therapy for me, and probably will be for you too.  Topics Discussed: → “Big Wellness” compared to “Big Pharma”   → Misconceptions about the MAHA movement  → Beef tallow at Steak 'n Shake → Why eating clean is actually cheaper than people think  → Toxic additives in baby formula   → Why current food guidelines are so backwards Sponsored By: → WeNatal | Get a free month's supply of WeNatal Magnesium with your first purchase at https://www.wenatal.com/realfoodology  → FPOO | Get your free $39 bottle for just $1 and taste the difference freshness makes at https://www.GetFresh324.com. → CURED | Right now, CURED Nutrition is offering my listeners an exclusive 20% off Serenity Gummies with a monthly subscription. Just head to https://www.curednutrition.com/REALFOODOLOGY and use the code REALFOODOLOGY at checkout. → Seed | Ready to experience a probiotic that actually works? Go to https://www.Seed.com/Realfoodology and use code 25Realfoodology to get 25% off your first month.  Timestamps:  → 00:00:00 - Introduction  → 00:01:37 - MAHA Misconceptions  → 00:08:45 - Healthier Eating Habits for Kids + Adults  → 00:15:35 - “Wellness Influencers” → 00:17:44 - Baby Formula  → 00:20:12 - Why We Can't Trust Our Medical Systems  → 00:26:32 - Science Needs to Keep Up   → 00:30:45 - Prioritizing Whole Ingredients   → 00:33:00 - The Math of Clean Eating   → 00:40:46 - Link Between Diet and Health  → 00:43:52 - What is “Big Wellness”?  → 00:50:06 - Michelle Obama + Kids' Health  → 00:53:20 - Kellogg's Corruption  → 00:54:38 - Studies + Regulations: E.U. vs. U.S.   → 00:58:07 - How Registered Dietitians Give Big Companies a Pass   → 01:00:29 - Our Current Food Guidelines Don't Work   Check Out: → Instagram | Iliriana Balaj  → Instagram | Live Healthillie  Check Out Courtney:  →  LEAVE US A VOICE MESSAGE →  Check Out My new FREE Grocery Guide! →  @realfoodology →  www.realfoodology.com →  My Immune Supplement by 2x4 →  Air Dr Air Purifier →  AquaTru Water Filter →  EWG Tap Water Database Produced By: Drake Peterson

Michelle Andrews built a career inside the pharma machine long before anyone knew what “DTC” meant. She helped launch Rituxan and watched Allegra commercials teach America how to ask for pills by name. Then she landed in the cancer fun house herself, stage 4 breast cancer, and learned exactly how hollow all the “journey” slide decks feel when you're the one circling the drain.We talk about what happens when the insider becomes the customer, why pill organizers and wheat field brochures still piss her off, and how she fired doctors who couldn't handle her will to live. You'll hear about the dawn of pharma advertising, the pre-Google advocacy hustle, and what she wants every brand team to finally admit about patient experience.If you've ever wondered who decided windsurfing was the best way to sell allergy meds—or what happens when you stop caring if you make people uncomfortable—listen up.RELATED LINKSMichelle Andrews on LinkedInTrinity Life Sciences – Strategic AdvisoryJade Magazine – Ticking Time Bombs ArticleNIHCM Foundation – Breast Cancer StoryFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Nashville SC take all 6 points this week and the team's 3 All stars keep the momentum going in the race for the supporters shield.  Thanks for listening! 

Two Women Inspiring Real Life with Stephanie Coxon and Kathy Anderson-Martin – Discover the contrast between pharmaceutical solutions and long-term wellness through fitness, nutrition, and education. Hear from a former pharmaceutical insider turned wellness advocate as we discuss the rise of chronic health conditions, the side effects of medications, and the lasting benefits of investing in exercise and a balanced, nutrient-rich...

Episode 98.  Does having privilege help or hurt you in gaining success in your career? What if being an underdog actually helped?In this episode of the Lifetime at Work Podcast, host Greg Martin interviews Quang X Pham, a Vietnamese refugee and accomplished entrepreneur. Quang shares his incredible journey from escaping Vietnam as a child to becoming a Marine Corps veteran, a biotech entrepreneur, and an author of two books. He discusses the challenges and motivations behind his success, from joining the military to navigating the pharmaceutical sales industry and eventually founding successful companies. Pham also provides practical advice on overcoming adversity, the importance of defining personal success, and the value of self-confidence and adaptability. His latest book, 'Underdog Nation,' aims to inspire those who feel like underdogs in their professional and personal lives. The episode captures his inspiring story, insights on entrepreneurship, and reflections on the immigrant experience in America.00:00 Introduction to the Podcast00:24 Meet Quang X Pham: A Journey of Resilience01:53 Early Life and Escape from Vietnam04:02 Adapting to Life in America05:54 Military Service and Lessons Learned10:44 Transition to the Business World13:21 Becoming an Entrepreneur18:39 Writing and Motivating Underdogs21:12 Presenting Yourself and Being Relatable21:59 Lessons from Military to Civilian Life23:53 Defining Success on Your Own Terms25:32 Transitioning from Corporate to Entrepreneurship28:21 Balancing Risk and Passion32:19 Dealing with the Past and Moving Forward36:15 Reflections on Vietnam and American Dream40:41 Advice for Underdogs and Career Advancement42:36 Conclusion and Final Thoughts

In today's episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India's decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.

What if you could transform your business by embracing cutting-edge technology and innovation? Join us for an eye-opening conversation with Jay Kulkarni, CEO of Theorem, who shares his remarkable journey of adapting to the fast-paced world of digital innovation. With over two decades of experience, Jay provides a masterclass in future-proofing your business, diving into the pivotal role of automation and AI in redefining business models for long-term success. From the revolutionary solution Upward to the intricacies of video commerce, discover how technology can streamline operations and create lasting value. Explore the profound impact of AI across industries as we unravel its efficiency in transforming sectors like pharma and media. Jay articulates the significance of identifying and alleviating friction points in advertising sales through technological advancements. But the conversation doesn't stop there. We also discuss the essential skills entrepreneurs need as their ventures grow, the strategic importance of investing in team development, and the art of risk management. Through stories of resilience during economic challenges, learn about the importance of playing the long game and nurturing internal talent to thrive in an ever-evolving market. Timestamps 00:00:00 - Introduction and Welcome to Business Legacy Podcast   00:00:04 - Conversation with Jay Kulkarni, CEO of Theorem   00:00:20 - Jay's Two-Decade Career in the Digital Space   00:01:00 - Importance of Adapting Business Models with Technological Change   00:02:30 - Integration of Automation and AI in Business Operations   00:04:03 - The Transformative Impact of AI in Various Industries   00:05:00 - AI's Role in Revolutionizing Processes and Creating New Value   00:06:30 - Discussion on Robotic Process Automation and Language Models   00:07:45 - Applications of AI in Pharma and Biosciences   00:09:00 - Projects Like Upward and Video Commerce Initiatives   00:10:30 - Friction Points in Media Advertising Sales   00:11:45 - Evolving Skills Needed for Entrepreneurs   00:13:31 - Evolution and Adaptation Strategies for Long-Term Success   00:14:45 - Emphasizing the Importance of Cross-Skilling and Up-Skilling   00:16:00 - Reflections on Economic Hardships and Risk Management   00:17:15 - Importance of Attitude and Soft Skills in Hiring   00:18:30 - Fostering Resourcefulness in Teams   00:19:45 - Navigating the Challenges of Legacy Business Owners   00:21:00 - Investing in Teams and Creating New Career Opportunities   00:22:15 - Tough Decisions During Economic Downturns   00:23:30 - Leadership Style and Communication Strategies   00:24:45 - Evolution from Web 1.0 to Web 3.0   00:26:00 - The Legacy of Value Creation and Servant Leadership   00:27:15 - Stories of Former Employees and Their Successes   00:28:30 - Conclusion and Final Thoughts from Jay Kulkarni   00:29:45 - Closing Remarks and Where to Find More Information About Theorem   Episode Resources: Connect with Jay here for more information: https://www.linkedin.com/in/jay-kulkarni-theorem/ Legacy Podcast: For more information about the Legacy Podcast and its co-hosts, visit businesslegacypodcast.com. Leave a Review: If you enjoyed the episode, leave a review and rating on your preferred podcast platform. For more information: Visit businesslegacypodcast.com to access the shownotes and additional resources on the episode.

Today at 11:11 am CST, on the Flyover Conservatives show we are tackling the most important things going on RIGHT NOW from a Conservative Christian perspective! Today at 11:11 am CST, on the Flyover Conservatives show we are tackling the most important things going on RIGHT NOW from a Conservative Christian perspective! TO WATCH ALL FLYOVER CONTENT: www.theflyoverapp.com TO WATCH ALL FLYOVER CONTENT: www.theflyoverapp.com To Schedule A Time To Talk To Dr. Dr. Kirk Elliott Go To To Schedule A Time To Talk To Dr. Dr. Kirk Elliott Go To ▶ https://flyovergold.com▶ https://flyovergold.comOr Call 720-605-3900 Or Call 720-605-3900 ► Receive your FREE 52 Date Night Ideas Playbook to make date night more exciting, go to www.prosperousmarriage.com► Receive your FREE 52 Date Night Ideas Playbook to make date night more exciting, go to www.prosperousmarriage.comJonathan OttoJonathan OttoWEBSITE: www.myredlight.comWEBSITE: www.myredlight.comUse Promo Code: FLYOVERUse Promo Code: FLYOVERJonathan Otto is a filmmaker, journalist, and health advocate dedicated to exploring natural health solutions and challenging mainstream narratives. Co-founding My Red Light, he aims to empower people by revealing lesser-known truths about wellness and alternative medicine. His work brings together insights from doctors and wellness experts worldwide, equipping audiences with knowledge for informed health choices. Through documentaries and series, Jonathan combines storytelling with a mission to inspire faith, integrity, and proactive health practices. His commitment to holistic wellness continues to impact lives and foster a community centered on empowerment and self-care.Jonathan Otto is a filmmaker, journalist, and health advocate dedicated to exploring natural health solutions and challenging mainstream narratives. Co-founding My Red Light, he aims to empower people by revealing lesser-known truths about wellness and alternative medicine. His work brings together insights from doctors and wellness experts worldwide, equipping audiences with knowledge for informed health choices. Through documentaries and series, Jonathan combines storytelling with a mission to inspire faith, integrity, and proactive health practices. His commitment to holistic wellness continues to impact lives and foster a community centered on empowerment and self-care.--------------------------------------------------------------------------------------

In this special episode of Molecule to Market, recorded at this year's CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturing sector. Raman is the panel moderator, joined by:  Gil Roth - PBOA Dr. Jim Li - BioDuro Sundia Kaan-Fabian Kekec - Simon-Kucher They unpack cautious optimism in the face of lingering market uncertainties and geopolitical tension, you'll hear: How CDMOs are adapting to early-stage funding strain and evolving pricing models The impact of rising interest rates, tariffs, and global trade policy on pharma outsourcing Capacity and talent constraints facing CDMOs in new therapeutic modalities Why integrated models and scenario planning are key to future-proofing operations This episode offers timely insight into the challenges and opportunities shaping the next phase of growth for CDMOs worldwide. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

Typically, Americans on the political Left worry about corporate power while those on the Right worry about government power. But the real danger is when corporations and government collude to dictate how you ought to live. We saw this during COVID, when experimental vaccines were pushed onto the American people, earning pharma companies big profits while they were shielded from any liability for the harm their products may cause. At this year's FreedomFest in Palm Springs, Matt Kibbe caught up with Del Bigtree, host of “The HighWire,” who has devoted most of his career to researching the vaccine industry. He points out that the pharma lobby is more powerful than the banks or even defense contractors and that they effectively control much of what our government does, meaning that our system is neither as capitalist nor as democratic as we imagine.

Dr. Anne Marie Morse walks into the studio like a one-woman Jersey Broadway show and leaves behind the best damn TED Talk you've never heard. She's a neurologist, sleep medicine doc, narcolepsy expert, founder of D.A.M.M. Good Sleep, and full-time myth buster in a white coat. We talk about why sleep isn't a luxury, why your mattress does matter, and how melatonin is the new Flintstones vitamin with a marketing budget. We unpack the BS around sleep hygiene, blow up the medical gaslighting around “disorders,” and dig into how a former aspiring butterfly became one of the loudest voices for patient-centered science. Also: naps, kids, burnout, CPAPs, co-sleeping, airport pods, the DeLorean, and Carl Sagan. If you think you're getting by on five hours of sleep and vibes, you're not. This episode will make you want to take a nap—and then call your doctor.RELATED LINKSdammgoodsleep.com: https://www.dammgoodsleep.comLinkedIn: https://www.linkedin.com/in/anne-marie-morse-753b2821/Instagram: https://www.instagram.com/dammgoodsleepDocWire News Author Page: https://www.docwirenews.com/author/anne-marie-morseSleep Review Interview: https://sleepreviewmag.com/practice-management/marketing/word-of-mouth/sleep-advocacy-anne-marie-morse/Geisinger Bio: https://providers.geisinger.org/provider/anne-marie-morse/756868SWHR Profile: https://swhr.org/team/anne-marie-morse-do-faasm/FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.